RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Abbott Laboratories

A collection of news and information related to Abbott Laboratories published by this site and its partners.

Top Abbott Laboratories Articles see all

Displaying items 1-5
  • Lew calls for 'economic patriotism,' seeks to limit offshore tax moves

    Lew calls for 'economic patriotism,' seeks to limit offshore tax moves
    Calling for "a new sense of economic patriotism," a top Obama administration official urged Congress to take immediate action to stop U.S. companies from reorganizing as foreign firms to avoid paying taxes.
  • Robert Depke, Lake County politician, dies at 84

     Robert Depke, Lake County politician, dies at 84
    Robert W. Depke, a major political player who twice served as chairman of the Lake County Board, was nicknamed "Bulldozer Bob" for his pro-development initiatives. But it was his role in the 1990s in helping to stop the closing and perhaps razing of...

    Virginia tops in controlling Medicaid fraud

    Virginia tops in controlling Medicaid fraud
    For a second time Virginia has taken top honors in the nation for its work eliminating waste and intercepting Medicaid fraud. The Office of the Inspector General presented the award Wednesday to Randy Clouse, director of the Virginia Medicaid Fraud...

    33 Illinois companies make Fortune 500 list

    33 Illinois companies make Fortune 500 list
    Thirty-three Illinois companies made the 2014 Fortune 500 list, Fortune magazine’s annual ranking of the top 500 corporations by gross revenue after adjustments and excise taxes. The figure is up from 32 companies that landed on the 2013 list...

    Abbott to sell portion of generic drug business for $5.3 billion

    Abbott to sell portion of generic drug business for $5.3 billion
    Abbott Laboratories has agreed to sell its branded generic drug business in developed countries to Mylan Inc. in a deal valued at $5.3 billion. The deal, announced Monday, allows the Chicago-area firm to shed its branded generic drug operations in...